Abstract
It is well recognized that biocatalysis is of special relevance in organic synthesis. Among the enzymes used, lipases have demonstrated a great versatility in enzymatic hydrolysis, transesterification, or aminolysis reactions. Other biocatalysts, such as oxidoreductases and some liases, are also of interest for organic chemists to synthesize compounds that are difficult to obtain by classical chemical procedures. Recently, biotransformations have shown their utility in natural products synthesis, such as in carbohydrates, steroids and nucleosides. Vitamin D, through its hormonally active form 1α,25-dihydroxyvitamin D3, plays an important role in the endocrine system. This metabolite exhibits a much broader spectrum of biological activities than expected. As a result, considerable effort has been made toward the synthesis of structurally related congeners that show interesting pharmacological applications. Most of the analogues prepared have modifications on the upper side chain, more accessible from a synthetic point of view. However, the enzymatic methodology can simplified the chemical routes allowing the synthesis of adequate precursors in a most simple way. We review here, the utility of biotransformations for the preparation of new Vitamin D analogues using different kind of biocatalysts.
Keywords: biocatalysis, vitamin D analogues, steroid modification
Current Organic Chemistry
Title: Biocatalysis Applied to the Synthesis of Vitamin D Analogues
Volume: 6 Issue: 5
Author(s): Susana Fernandez, Vicente Gotor-Fernandez, Miguel Ferrero and Vicente Gotor
Affiliation:
Keywords: biocatalysis, vitamin D analogues, steroid modification
Abstract: It is well recognized that biocatalysis is of special relevance in organic synthesis. Among the enzymes used, lipases have demonstrated a great versatility in enzymatic hydrolysis, transesterification, or aminolysis reactions. Other biocatalysts, such as oxidoreductases and some liases, are also of interest for organic chemists to synthesize compounds that are difficult to obtain by classical chemical procedures. Recently, biotransformations have shown their utility in natural products synthesis, such as in carbohydrates, steroids and nucleosides. Vitamin D, through its hormonally active form 1α,25-dihydroxyvitamin D3, plays an important role in the endocrine system. This metabolite exhibits a much broader spectrum of biological activities than expected. As a result, considerable effort has been made toward the synthesis of structurally related congeners that show interesting pharmacological applications. Most of the analogues prepared have modifications on the upper side chain, more accessible from a synthetic point of view. However, the enzymatic methodology can simplified the chemical routes allowing the synthesis of adequate precursors in a most simple way. We review here, the utility of biotransformations for the preparation of new Vitamin D analogues using different kind of biocatalysts.
Export Options
About this article
Cite this article as:
Fernandez Susana, Gotor-Fernandez Vicente, Ferrero Miguel and Gotor Vicente, Biocatalysis Applied to the Synthesis of Vitamin D Analogues, Current Organic Chemistry 2002; 6 (5) . https://dx.doi.org/10.2174/1385272024604961
DOI https://dx.doi.org/10.2174/1385272024604961 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Osteoimmunology and Beyond
Current Medicinal Chemistry Pro-Inflammatory Cytokines: New Potential Therapeutic Targets for Obesity-Related Bone Disorders
Current Drug Targets Meet the Editorial Board Member
Current Medicinal Chemistry The Search for Immunosuppressive Therapies to Induce Tolerance in Organ Transplantation
Endocrine, Metabolic & Immune Disorders - Drug Targets Bioinformatics Approach for Data Capturing: The Case of Breast Cancer
Current Cancer Therapy Reviews Mechanisms Explaining the Influence of Subclinical Hypothyroidism on the Onset and Progression of Chronic Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets PepT1, ASBT-Linked Prodrug Strategy to Improve Oral Bioavailability and Tissue Targeting Distribution
Current Drug Metabolism Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development)
Current Pharmaceutical Design Role of Gut Microbiota in Obesity, Type 2 Diabetes and Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Current & Future Therapies of Erectile Dysfunction in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Novel Possible Pharmaceutical Research Tools: Stem Cells, Gene Delivery and their Combination
Current Pharmaceutical Design Cross-Talk Between Adipose Tissue Health, Myocardial Metabolism and Vascular Function: The Adipose-Myocardial and Adipose-Vascular Axes
Current Pharmaceutical Design Patents in Targets and Drugs for Insulin Resistance: Correlation with Inflammatory Mediators
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Effect of Flavonoids on Human Health: Old Subjects but New Challenges
Recent Patents on Biotechnology Inflammation, Adipocytokines, and Atherosclerosis in the Metabolic Syndrome
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Vitamin D and Physical Performance in Athletes
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) New Insights Toward Nanostructured Drug Delivery of Plant-Derived Polyphenol Compounds: Cancer Treatment and Gene Expression Profiles
Current Cancer Drug Targets Association of Hypothyroidism with Body Mass Index, Systolic Blood Pressure and Proteinuria in Diabetic Patients: Does treated Hypothyroidism with Thyroxine Replacement Therapy Prevent Nephropathy/Chronic Renal Disease?
Current Diabetes Reviews Patent Selections:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery MHC Class I TCR Engineered Anti-Tumor CD4 T Cells: Implications For Cancer Immunotherapy
Endocrine, Metabolic & Immune Disorders - Drug Targets